Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,028,857 | -204,149 | -623,506 | -595,625 | -823,605 |
| Depreciation Amortization | 1,084,319 | 207,229 | 213,527 | 200,556 | 376,123 |
| Income taxes - deferred | -10,119 | -955 | -11,901 | -253,169 | -6,748 |
| Accounts receivable | -46,259 | -43,416 | 61,088 | 25,150 | -100,526 |
| Accounts payable and accrued liabilities | 43,538 | 82,750 | -52,180 | 169,800 | 55,165 |
| Other Working Capital | -56,012 | -342 | -26,377 | 111,109 | -42,269 |
| Other Operating Activity | 223,926 | 115,002 | 215,790 | 239,943 | 678,342 |
| Operating Cash Flow | $210,536 | $156,119 | $-223,559 | $-102,236 | $136,482 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -259,210 | 223,302 | 321,586 | -369,728 | -203,278 |
| PPE Investments | -180,989 | -124,690 | -189,462 | -193,839 | -476,499 |
| Net Acquisitions | N/A | -52,413 | -14,686 | -499,730 | -6,658 |
| Purchase Of Investment | -1,731 | -16,564 | -42,823 | -18,044 | -15,947 |
| Sale Of Investment | N/A | 19,794 | N/A | N/A | N/A |
| Other Investing Activity | -225 | 250 | -549 | -744 | 345 |
| Investing Cash Flow | $-442,155 | $49,679 | $74,066 | $-1,082,085 | $-702,037 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 266,750 | 137,976 | 0 | 0 | 1,125,547 |
| Debt Repayment | N/A | N/A | N/A | N/A | -150,054 |
| Common Stock Issued | 32,878 | 31,541 | 32,015 | 37,507 | 907,133 |
| Other Financing Activity | -67,754 | -9,751 | 44,470 | -29,035 | -3,005 |
| Financing Cash Flow | $231,874 | $159,766 | $76,485 | $8,472 | $1,879,621 |
| Exchange Rate Effect | -3,294 | 1,321 | 30 | 23 | N/A |
| Beginning Cash Position | 609,675 | 242,790 | 315,768 | 1,491,594 | 177,528 |
| End Cash Position | 606,636 | 609,675 | 242,790 | 315,768 | 1,491,594 |
| Net Cash Flow | $-3,039 | $366,885 | $-72,978 | $-1,175,826 | $1,314,066 |
| Free Cash Flow | |||||
| Operating Cash Flow | 210,536 | 156,119 | -223,559 | -102,236 | 136,482 |
| Capital Expenditure | -180,989 | -124,690 | -214,462 | -193,839 | -476,499 |
| Free Cash Flow | 29,547 | 31,429 | -438,021 | -296,075 | -340,017 |